# Belviq (lorcaserin) market withdrawal and cancer concerns

> Why the weight loss drug was pulled from the market after cancer signal findings.

**Canonical URL:** https://drugsmonitor.com/guides/belviq-weight-loss-drug-cancer
**Last updated:** 2026-06-11

Belviq (lorcaserin) was an FDA-approved weight management drug voluntarily withdrawn from the US market in 2020 after a safety clinical trial found a higher rate of cancer diagnoses among patients taking the drug compared to placebo.

Various cancers were observed including pancreatic, colorectal, and lung malignancies. The FDA recommended that patients stop taking lorcaserin and discuss alternatives with their providers.

If you took Belviq or generic lorcaserin and were subsequently diagnosed with cancer, preserve your prescription records and consult with a qualified attorney about filing deadlines.

---

*Educational guide from DrugsMonitor.com. Not legal advice.*